• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含Dmt-Tic阿片类药效基团的双功能铅μ激动剂/δ拮抗剂的演变

Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore.

作者信息

Balboni Gianfranco, Salvadori Severo, Trapella Claudio, Knapp Brian I, Bidlack Jean M, Lazarus Lawrence H, Peng Xuemei, Neumeyer John L

机构信息

Department of Toxicology, University of Cagliari, I-09124, Cagliari, Italy.

出版信息

ACS Chem Neurosci. 2010 Feb 17;1(2):155-164. doi: 10.1021/cn900025j.

DOI:10.1021/cn900025j
PMID:20352071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2843921/
Abstract

Based on a renewed importance recently attributed to bi- or multifunctional opioids, we report the synthesis and pharmacological evaluation of some analogues derived from our lead μ agonist / δ antagonist, H-Dmt-Tic-Gly-NH-Bzl. Our previous studies focused on the importance of the C-teminal benzyl function in the induction of such bifunctional activity. The introduction of some substituents in the para position of the phenyl ring (-Cl, -CH(3), partially -NO(2), inactive -NH(2)) was found to give a more potent μ agonist / antagonist effect associated with a relatively unmodified δ antagonist activity (pA(2) = 8.28-9.02). Increasing the steric hindrance of the benzyl group (using diphenylmethyl and tetrahydroisoquinoline functionalities) substantially maintained the μ agonist and δ antagonist activities of the lead compound. Finally and quite unexpectedly D-Tic2, considered as a wrong opioid message now; inserted into the reference compound in lieu of L-Tic, provided a μ agonist / δ agonist better than our reference ligand (H-Dmt-Tic-Gly-NH-Ph) and was endowed with the same pharmacological profile.

摘要

基于双功能或多功能阿片类药物最近重新受到的重视,我们报告了一些源自我们的先导μ激动剂/δ拮抗剂H-Dmt-Tic-Gly-NH-Bzl的类似物的合成及药理学评价。我们之前的研究聚焦于C末端苄基官能团在诱导这种双功能活性中的重要性。发现在苯环的对位引入一些取代基(-Cl、-CH(3)、部分-NO(2)、无活性的-NH(2))会产生更强的μ激动剂/拮抗剂效应,同时δ拮抗剂活性相对未改变(pA(2)=8.28 - 9.02)。增加苄基的空间位阻(使用二苯甲基和四氢异喹啉官能团)基本维持了先导化合物的μ激动剂和δ拮抗剂活性。最后且相当出乎意料的是,D-Tic2现在被认为是错误的阿片类信息;将其代替L-Tic插入参考化合物中,得到了一种比我们的参考配体(H-Dmt-Tic-Gly-NH-Ph)更好的μ激动剂/δ激动剂,并且具有相同的药理学特征。

相似文献

1
Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore.含Dmt-Tic阿片类药效基团的双功能铅μ激动剂/δ拮抗剂的演变
ACS Chem Neurosci. 2010 Feb 17;1(2):155-164. doi: 10.1021/cn900025j.
2
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.Dmt-Tic药效团的评估:将一种强效δ-阿片受体拮抗剂转化为强效δ-激动剂以及具有混合性质的配体。
J Med Chem. 2002 Jan 31;45(3):713-20. doi: 10.1021/jm010449i.
3
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.Dmt-Tic阿片类药物药效基团C末端赖氨酸的作用。
J Med Chem. 2006 Sep 7;49(18):5610-7. doi: 10.1021/jm060741w.
4
N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.TIPP(Tyr-Tic-Phe-Phe)肽的 N-末端胍基化导致阿片活性谱的重大变化。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5082-5. doi: 10.1016/j.bmcl.2013.07.036. Epub 2013 Jul 23.
5
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.对含有阿片类药效基团Dmt-Tic的先导化合物的进一步研究。
J Med Chem. 2008 Aug 28;51(16):5109-17. doi: 10.1021/jm800587e. Epub 2008 Aug 5.
6
Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.双功能 μ/δ 阿片肽:连接两个部分的连接体的类型和长度的变化。
Chem Biol Drug Des. 2012 Feb;79(2):186-93. doi: 10.1111/j.1747-0285.2011.01268.x. Epub 2012 Jan 4.
7
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.对Dmt-Tic药效基团的进一步研究:C末端的疏水取代基赋予δ拮抗剂表现出μ激动或μ拮抗作用。
J Med Chem. 1999 Dec 2;42(24):5010-9. doi: 10.1021/jm990165m.
8
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.Dmt-Tic药效团中C末端取代氨基酸对δ-阿片受体选择性和拮抗作用的直接影响。
J Med Chem. 2004 Jul 29;47(16):4066-71. doi: 10.1021/jm040033f.
9
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.含有Dmt-Tic药效基团的强效δ-阿片受体激动剂。
J Med Chem. 2002 Dec 5;45(25):5556-63. doi: 10.1021/jm020336e.
10
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.Dmt-Tic药效基团的演变:具有非凡δ阿片受体拮抗剂活性的N-末端甲基化衍生物。
J Med Chem. 1997 Sep 12;40(19):3100-8. doi: 10.1021/jm9607663.

引用本文的文献

1
Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.新型阿片类配体UTA1003对镇痛耐受性和运动行为的不同影响。
Pharmaceuticals (Basel). 2022 Jun 24;15(7):789. doi: 10.3390/ph15070789.
2
In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity.体内、体外和计算机模拟研究混合化合物 AA3266,一种具有选择性细胞毒性的阿片类激动剂/NK1R 拮抗剂。
Int J Mol Sci. 2020 Oct 19;21(20):7738. doi: 10.3390/ijms21207738.
3
Structure-Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics.7-取代二甲基酪氨酸-四氢异喹啉阿片肽类似物的构效关系。
Molecules. 2019 Nov 26;24(23):4302. doi: 10.3390/molecules24234302.
4
Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show Kappa and Mu Opioid Receptor Agonism.新型含芳香四氢异喹啉取代基的二甲基酪氨酸-四氢异喹啉肽拟似物具有 κ 和 μ 阿片受体激动活性。
ACS Chem Neurosci. 2019 Aug 21;10(8):3682-3689. doi: 10.1021/acschemneuro.9b00250. Epub 2019 Jul 1.
5
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.同时激活μ阿片受体和δ阿片受体可减轻神经病理性疼痛动物模型的痛觉过敏和星形胶质细胞连接蛋白 43。
Mol Neurobiol. 2019 Nov;56(11):7338-7354. doi: 10.1007/s12035-019-1607-1. Epub 2019 Apr 28.
6
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.体外和体内鉴定双功能 μ 和 δ 阿片受体配体 UFP-505。
Br J Pharmacol. 2018 Jul;175(14):2881-2896. doi: 10.1111/bph.14199. Epub 2018 May 14.
7
Synthesis and Investigation of Mixed μ-Opioid and δ-Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain.混合μ-阿片和δ-阿片激动剂作为治疗疼痛的潜在双价配体的合成与研究
J Heterocycl Chem. 2017 Mar;54(2):1228-1235. doi: 10.1002/jhet.2696. Epub 2016 Jun 1.
8
Targeting multiple opioid receptors - improved analgesics with reduced side effects?靶向多个阿片受体——减少副作用的改善型镇痛药?
Br J Pharmacol. 2018 Jul;175(14):2857-2868. doi: 10.1111/bph.13809. Epub 2017 May 26.
9
Rapid Synthesis of Boc-2',6'-dimethyl-l-tyrosine and Derivatives and Incorporation into Opioid Peptidomimetics.Boc-2',6'-二甲基-L-酪氨酸及其衍生物的快速合成与掺入阿片样肽模拟物中
ACS Med Chem Lett. 2015 Oct 19;6(12):1199-203. doi: 10.1021/acsmedchemlett.5b00344. eCollection 2015 Dec 10.
10
Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.使用乌吉多组分反应合成卡芬太尼酰胺类阿片药物。
ACS Chem Neurosci. 2015 Sep 16;6(9):1570-7. doi: 10.1021/acschemneuro.5b00137. Epub 2015 Jul 21.

本文引用的文献

1
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile.同时靶向多种阿片受体:一种改善副作用情况的策略。
Br J Anaesth. 2009 Jul;103(1):38-49. doi: 10.1093/bja/aep129. Epub 2009 May 27.
2
Bi- or multifunctional opioid peptide drugs.双功能或多功能阿片肽药物。
Life Sci. 2010 Apr 10;86(15-16):598-603. doi: 10.1016/j.lfs.2009.02.025. Epub 2009 Mar 11.
3
Design of multivalent ligand targeting G-protein-coupled receptors.靶向G蛋白偶联受体的多价配体设计
Curr Pharm Des. 2009;15(6):682-718. doi: 10.2174/138161209787315639.
4
Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.ATPM [(-)-3-氨基噻唑并[5,4-b]-N-环丙基甲基吗啡喃盐酸盐] 的药理学特性,一种新型的κ激动剂和μ激动剂/拮抗剂混合物,可减轻吗啡抗伤害感受耐受性和海洛因自我给药行为。
J Pharmacol Exp Ther. 2009 Apr;329(1):306-13. doi: 10.1124/jpet.108.142802. Epub 2009 Jan 9.
5
Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys.δ阿片类药物效能在恒河猴μ/δ阿片类药物相互作用中的决定作用。
Eur J Pharmacol. 2009 Jan 5;602(1):92-100. doi: 10.1016/j.ejphar.2008.11.004. Epub 2008 Nov 11.
6
In vivo trafficking of endogenous opioid receptors.内源性阿片受体的体内运输
Life Sci. 2008 Nov 21;83(21-22):693-9. doi: 10.1016/j.lfs.2008.09.023. Epub 2008 Oct 5.
7
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential.孤啡肽/痛敏肽受体:一个具有广泛治疗潜力的靶点。
Nat Rev Drug Discov. 2008 Aug;7(8):694-710. doi: 10.1038/nrd2572.
8
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia.环氧化酶-2(COX-2)抑制剂塞来昔布可预防慢性吗啡诱导的血管生成、肿瘤生长、转移及死亡率增加,且不影响镇痛效果。
Br J Cancer. 2007 Dec 3;97(11):1523-31. doi: 10.1038/sj.bjc.6604057. Epub 2007 Oct 30.
9
Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.比较鞘内注射脑啡肽产生的镇痛作用和μ-阿片受体内化:肽酶抑制的必要性。
Neuropharmacology. 2007 Oct;53(5):664-76. doi: 10.1016/j.neuropharm.2007.07.010. Epub 2007 Aug 2.
10
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.Dmt-Tic阿片类药物药效基团C末端赖氨酸的作用。
J Med Chem. 2006 Sep 7;49(18):5610-7. doi: 10.1021/jm060741w.